Pharmgenomics Pers Med
February 2022
Cystic fibrosis (CF) is an autosomal recessive genetic condition that is caused by variants in the gene. This causes multisystem disease due to dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) ion channel at the apical surface of epithelia. Until recently, treatment was directed at managing the downstream effects in affected organs, principally improving airway clearance and treating infection in the lungs and improving malabsorption in the gastrointestinal tract.
View Article and Find Full Text PDF